Jiangsu Bioperfectus Technologies Co Ltd Total Liabilities
Jiangsu Bioperfectus Technologies Co Ltd total liabilities. Based on the latest financial reports, Jiangsu Bioperfectus Technologies Co Ltd (688399) has total liabilities worth CN¥681.04 Million CNY (≈ $99.66 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 688399 financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Jiangsu Bioperfectus Technologies Co Ltd (2016–2024)
Total liabilities of Jiangsu Bioperfectus Technologies Co Ltd from 2016 to 2024. This chart illustrates how Jiangsu Bioperfectus Technologies Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Jiangsu Bioperfectus Technologies Co Ltd Competitors by Total Liabilities
The table below lists competitors of Jiangsu Bioperfectus Technologies Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
G Willi-Food International Ltd
TA:WILC
|
Israel | ILA75.03 Million |
|
Envipco Holding N.V.
AS:ENVI
|
Netherlands | €55.32 Million |
|
Brooge Holdings Ltd
NASDAQ:BROG
|
USA | $429.22 Million |
|
Shanxi C&Y Pharmaceutical Group Co Ltd
SHE:300254
|
China | CN¥1.00 Billion |
|
Jiangsu Safety Wire Rope
SHG:603028
|
China | CN¥2.17 Billion |
|
Eastern Pioneer Auto Driving S
SHG:603377
|
China | CN¥2.98 Billion |
|
Vista Gold Corporation
NYSE MKT:VGZ
|
USA | $1.20 Million |
|
F-SECURE OYJ
HE:FSECURE
|
Finland | €204.90 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Jiangsu Bioperfectus Technologies Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Jiangsu Bioperfectus Technologies Co Ltd assets under control.
Liquidity & Leverage Metrics
Jiangsu Bioperfectus Technologies Co Ltd Total Liabilities Ratios Explained
Jiangsu Bioperfectus Technologies Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jiangsu Bioperfectus Technologies Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jiangsu Bioperfectus Technologies Co Ltd (2016–2024)
The table below shows the annual total liabilities of Jiangsu Bioperfectus Technologies Co Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥489.32 Million ≈ $71.60 Million |
-2.39% |
| 2023-12-31 | CN¥501.31 Million ≈ $73.36 Million |
-54.95% |
| 2022-12-31 | CN¥1.11 Billion ≈ $162.84 Million |
+15.57% |
| 2021-12-31 | CN¥962.89 Million ≈ $140.90 Million |
+57.03% |
| 2020-12-31 | CN¥613.18 Million ≈ $89.73 Million |
+359.06% |
| 2019-12-31 | CN¥133.57 Million ≈ $19.55 Million |
+86.91% |
| 2018-12-31 | CN¥71.46 Million ≈ $10.46 Million |
+41.88% |
| 2017-12-31 | CN¥50.37 Million ≈ $7.37 Million |
+47.74% |
| 2016-12-31 | CN¥34.09 Million ≈ $4.99 Million |
-- |
About Jiangsu Bioperfectus Technologies Co Ltd
Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. The company offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. It also provides HPV and cervical cancer testing services, respiratory infection detection solution, … Read more